COVID-19 Testing: More details
COVID-19 Resources: More details
DESHLER, Ohio--(BUSINESS WIRE)--#G63--Graminex®, L.L.C. is pleased to announce that it has received its Foreign Site Reference Number from Health Canada. Graminex received the FSRN NOTICE OF ACCEPTANCE authorizing the company to manufacture, package, an
The licenced producer can now sell to distributors and retailers across Canada BOISBRIAND, Quebec--(BUSINESS WIRE)--Navaya Inc., an innovative Quebec-based cannabis producer, today received from Health Canada its sales licence to sell dried cannabis prod
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Gensource Potash Corporation (“Gensource” or the “Company”) (TSXV: GSP) today announces that it has completed the previously announced non-brokered private placement offering (the “Offering”) of up to
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Gensource Potash Corporation ("Gensource" or the "Company") (TSX.V: GSP), a fertilizer development company focused on sustainable potash production, announces the filing of an updated National Instrument (“NI”
VANCOUVER, British Columbia--(BUSINESS WIRE)--Evasc Neurovascular is proud to announce the third generation of its eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter. The new device is classified as a flow diverter, with a leaf density of 35%, which
Inter-disciplinary event becomes an Innovation platform, attracting global healthcare investors TOKYO--(BUSINESS WIRE)--Alfred Patisenah and Daisy Ramadhani of School of Life Sciences and Technology, Indonesia, won the prestigious Fujio Cup Quiz (FCQ), a
MUNICH & GARCHING, Germany & CHALK RIVER, Ontario--(BUSINESS WIRE)--ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology organization,
6.3 tonne order represents a 43% increase over most recent shipment to same customer Growth during pandemic signals strong impact on market share through use of OxC-beta™ OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“A
Phase 1 clinical study to assess effect of cudetaxestat on pharmacokinetics of two approved therapies for idiopathic pulmonary fibrosis (IPF) Company on track to initiate planned phase 2 clinical study of cudetaxestat in IPF in 1H-2022 SOUTH SAN FRA
Company now averages 15,000 tests per week through on-site, in-clinic and new COVIDdetect DIY testing service, helping companies manage complexities of testing for employees, contractors, students and event goers AYR, Ontario--(BUSINESS WIRE)--DriverChec
Individuals who currently have a digital Manitoba immunization card or are applying for one can visit immunizationcard.Manitoba.ca or call 1-844-MAN-VACC (1-844-626-8222) to request their PVC, in digital or hard copy.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.